BusinessOHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessOHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessImmune Design to Report First Quarter 2017 Financial Results & Provide Corporate UpdateBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessImmune Design to Report First Quarter 2017 Financial Results & Provide Corporate UpdateBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessImmune Design to Report First Quarter 2017 Financial Results & Provide Corporate UpdateBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessFibrocell Announces Data Safety Monitoring Board Recommends Continuation of Phase 1/2 Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis BullosaBy Nasdaq OMXMay 8, 2017, 12:00 PM UTC
BusinessNewLink Genetics to Participate in Upcoming Investor ConferencesBy Nasdaq OMXMay 8, 2017, 11:00 AM UTC
BusinessMyriad Genetics to Present Results from Four Studies at the American Urological Association 2017 Annual MeetingBy Nasdaq OMXMay 5, 2017, 11:05 AM UTC
